Eflucimibe
Eflucimibe (L0081) is an ACAT inhibitor used in research to study atherosclerosis and hyperlipidemia. It is applied in both in vitro enzymatic assays and in vivo animal models to investigate lipid metabolism and cardiovascular disease mechanisms.
Product Specifications
CAS Number
202340-45-2
Product Name Alternative
ACAT, L0081, L-0081, L 0081, F12511, F-12511, F 12511, Eflucimibe
Field of Research
Metabolism Research
Purity
98.56% (May vary between batches)
Solubility
10% DMSO+90% Corn Oil:1.5 mg/mL (3.19 mM) ; DMSO:15 mg/mL (31.93 mM)
Smiles
[C@H] (C (NC1=C (C) C (C) =C (O) C (C) =C1) =O) (SCCCCCCCCCCCC) C2=CC=CC=C2
Molecular Formula
C29H43NO2S
Molecular Weight
469.72
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS1468256 Inquire
Recombinant Campylobacter jejuni 5-methyltetrahydropteroyltriglutamate--homocysteine methyltransferase (metE), partial
Sign In for Pricing
View Details 
E2213-92-ML650 100 µL
TUFM, NT (Elongation Factor Tu, Mitochondrial, EF-Tu, P43) (MaxLight 650) discontinued
Sign In for Pricing
View Details K0782402 1.0 µg DNA
FIBCD1 sgRNA CRISPR Lentivector (Human) (Target 1)
Sign In for Pricing
View Details